The US Food and Drug Administration (FDA) yesterday published the guidance for industry, “Requests for Reconsideration at the ...

US RNA medicines biotech Wave Life Sciences yesterday announced positive proof-of-mechanism data from the ongoing Phase ...

Sanofi has partnered with Orano Med, a subsidiary of Orano Group, to develop radioligand therapies for rare cancers. Sanofi ...

Japanese drug major Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), ...

At the European Cell and Gene Therapy Summit 2024, confidence in the sector’s maturity and progress was evident, highlighted ...

ViiV Healthcare, the specialist HIV company majority owned by GSK (LSE: GSK), today announced the presentation of new ...

Eli Lilly has announced a strategic collaboration with UK government departments to address population health challenges, ...

A staggering 800% increase in licensing agreement deal values for messenger ribonucleic acid (mRNA)-based innovator ...

Netherlands-based venture capital firm Forbion has raised over €2 billion ($2.2 billion) across its newest funds, bringing ...

California-based Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration ...

The American Lung Association Research Institute has announced a $22 million investment in 2024 to fund 139 research grants ...

TenNor Therapeutics has raised over 300 million yuan ($41 million) in a series E round, led by AMR Action Fund, to advance ...